Global HIV-1 Testing Market Research Report 2023

Publication ID:

PB510230638

Publication Date:

October 19, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

HIV tests are very accurate, but no test can detect the virus immediately after infection. How soon a test can detect HIV depends upon different factors, including the type of test being used. There are three types of HIV diagnostic tests: nucleic acid tests (NAT), antigen/antibody tests, and antibody tests.
The global HIV-1 Testing market is projected to reach US$ 7920.9 million in 2029, increasing from US$ 4132 million in 2022, with the CAGR of 9.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HIV-1 Testing 91制片厂.
The HIV-1 Testing market is primarily driven by the ongoing efforts to combat the global HIV epidemic and the need for accurate and accessible diagnostic tools. HIV-1 testing plays a crucial role in early detection, treatment initiation, and prevention of HIV transmission. The growing awareness of the importance of early diagnosis, coupled with the expansion of HIV testing initiatives and public health campaigns, contributes to market growth. Moreover, advancements in testing technologies, such as rapid point-of-care tests and nucleic acid-based assays, further propel adoption. However, challenges include addressing stigma associated with HIV testing and ensuring equitable access to testing in underserved regions. Navigating quality assurance, providing counseling services, and keeping up with evolving viral strains are ongoing concerns. The market's success relies on continuous innovation in testing methods, collaborations between diagnostic manufacturers and healthcare providers, and comprehensive education on the benefits of HIV-1 testing while addressing the evolving challenges associated with HIV prevention, diagnosis, and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global HIV-1 Testing market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Abbott
Bio-Rad Laboratories
National Genetics Institute
Roche
Grifols Diagnostics
bioMerieux
CSL
Hologic
Takeda
Segment by Type
Antibody
Nucleic Acid Testing
Antigen
Segment by Application
Hospital
Independent Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The HIV-1 Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV-1 Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antibody
1.2.3 Nucleic Acid Testing
1.2.4 Antigen
1.3 Market by Application
1.3.1 Global HIV-1 Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Independent Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV-1 Testing Market Perspective (2018-2029)
2.2 HIV-1 Testing Growth Trends by Region
2.2.1 Global HIV-1 Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 HIV-1 Testing Historic Market Size by Region (2018-2023)
2.2.3 HIV-1 Testing Forecasted Market Size by Region (2024-2029)
2.3 HIV-1 Testing Market Dynamics
2.3.1 HIV-1 Testing Industry Trends
2.3.2 HIV-1 Testing Market Drivers
2.3.3 HIV-1 Testing Market Challenges
2.3.4 HIV-1 Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV-1 Testing Players by Revenue
3.1.1 Global Top HIV-1 Testing Players by Revenue (2018-2023)
3.1.2 Global HIV-1 Testing Revenue Market Share by Players (2018-2023)
3.2 Global HIV-1 Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV-1 Testing Revenue
3.4 Global HIV-1 Testing Market Concentration Ratio
3.4.1 Global HIV-1 Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV-1 Testing Revenue in 2022
3.5 HIV-1 Testing Key Players Head office and Area Served
3.6 Key Players HIV-1 Testing Product Solution and Service
3.7 Date of Enter into HIV-1 Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV-1 Testing Breakdown Data by Type
4.1 Global HIV-1 Testing Historic Market Size by Type (2018-2023)
4.2 Global HIV-1 Testing Forecasted Market Size by Type (2024-2029)
5 HIV-1 Testing Breakdown Data by Application
5.1 Global HIV-1 Testing Historic Market Size by Application (2018-2023)
5.2 Global HIV-1 Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America HIV-1 Testing Market Size (2018-2029)
6.2 North America HIV-1 Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America HIV-1 Testing Market Size by Country (2018-2023)
6.4 North America HIV-1 Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV-1 Testing Market Size (2018-2029)
7.2 Europe HIV-1 Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe HIV-1 Testing Market Size by Country (2018-2023)
7.4 Europe HIV-1 Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV-1 Testing Market Size (2018-2029)
8.2 Asia-Pacific HIV-1 Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific HIV-1 Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific HIV-1 Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV-1 Testing Market Size (2018-2029)
9.2 Latin America HIV-1 Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America HIV-1 Testing Market Size by Country (2018-2023)
9.4 Latin America HIV-1 Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV-1 Testing Market Size (2018-2029)
10.2 Middle East & Africa HIV-1 Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa HIV-1 Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa HIV-1 Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott HIV-1 Testing Introduction
11.1.4 Abbott Revenue in HIV-1 Testing Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories HIV-1 Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in HIV-1 Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 National Genetics Institute
11.3.1 National Genetics Institute Company Detail
11.3.2 National Genetics Institute Business Overview
11.3.3 National Genetics Institute HIV-1 Testing Introduction
11.3.4 National Genetics Institute Revenue in HIV-1 Testing Business (2018-2023)
11.3.5 National Genetics Institute Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche HIV-1 Testing Introduction
11.4.4 Roche Revenue in HIV-1 Testing Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Grifols Diagnostics
11.5.1 Grifols Diagnostics Company Detail
11.5.2 Grifols Diagnostics Business Overview
11.5.3 Grifols Diagnostics HIV-1 Testing Introduction
11.5.4 Grifols Diagnostics Revenue in HIV-1 Testing Business (2018-2023)
11.5.5 Grifols Diagnostics Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Detail
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux HIV-1 Testing Introduction
11.6.4 bioMerieux Revenue in HIV-1 Testing Business (2018-2023)
11.6.5 bioMerieux Recent Development
11.7 CSL
11.7.1 CSL Company Detail
11.7.2 CSL Business Overview
11.7.3 CSL HIV-1 Testing Introduction
11.7.4 CSL Revenue in HIV-1 Testing Business (2018-2023)
11.7.5 CSL Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic HIV-1 Testing Introduction
11.8.4 Hologic Revenue in HIV-1 Testing Business (2018-2023)
11.8.5 Hologic Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda HIV-1 Testing Introduction
11.9.4 Takeda Revenue in HIV-1 Testing Business (2018-2023)
11.9.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott
Bio-Rad Laboratories
National Genetics Institute
Roche
Grifols Diagnostics
bioMerieux
CSL
Hologic
Takeda

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.